Do Smokers Have Elevated ANA Typically?
No, smokers do not typically have elevated ANA levels—in fact, the opposite appears to be true: active smoking is associated with lower ANA prevalence compared to non-smokers.
The Evidence on Smoking and ANA
The relationship between smoking and ANA is counterintuitive but consistently demonstrates an inverse association:
Lower ANA Prevalence in Active Smokers
The most comprehensive data shows that active smokers have reduced odds of ANA positivity compared to non-smokers. In a large US population study, ANA prevalence was:
- Highest in non-smokers (13.3-19.2%)
- Lower in passive smokers (11.1-15.5%)
- Lowest in active smokers (7.4-13.3%)
Active smokers had significantly reduced odds of ANA in 1999-2004 (OR 0.65,95% CI 0.45-0.93), though this protective effect weakened somewhat by 2011-2012 (OR 0.82,95% CI 0.56-1.21) 1.
Older Studies Show Conflicting Results
Two older studies from the late 1980s-early 1990s reported higher prevalence of ANAs in elderly smokers compared to non-smokers 2, 3. However, these studies were limited to subjects over 45 years of age and had much smaller sample sizes, making them less generalizable than the more recent population-based data.
Disease-Specific Context Matters
In patients with established COPD, ANAs are more prevalent (OR 3.12,95% CI 1.68-5.76), but this association is not related to smoking status itself—rather, it correlates with low BMI (<22 kg/m²) and the presence of COPD disease 4. Similarly, in established SLE patients, current smoking showed no clear association with autoantibody production 5.
Clinical Interpretation
Key Points for Practice:
- Do not expect elevated ANA in smokers based on smoking history alone
- The protective effect of smoking against ANA may relate to carbon monoxide or other smoke components that modulate immune responses
- When you encounter a positive ANA in a smoker, interpret it the same way you would in a non-smoker—the clinical significance depends on titer, pattern, specific autoantibodies, and clinical context per standard guidelines 6
Important Caveats:
- The inverse relationship between smoking and ANA does not mean smoking is protective against autoimmune disease—smoking increases risk for certain autoimmune conditions (like rheumatoid arthritis) through mechanisms independent of ANA production 5
- Recent increases in ANA prevalence among adolescent smokers may relate to e-cigarette use, which delivers less carbon monoxide than traditional cigarettes 1
- In patients with established autoimmune disease or COPD, the relationship between smoking and autoantibodies becomes more complex and disease-specific
Standard ANA Interpretation Applies:
Regardless of smoking status, follow established guidelines 6:
- ANA screening dilution of 1:160 is generally appropriate for adults
- Positive ANA requires clinical correlation—up to 25% of healthy individuals can be ANA positive at lower dilutions
- Pattern recognition and specific autoantibody testing guide diagnosis
- ANA testing is for diagnosis, not monitoring disease activity
Bottom line: Smoking does not cause elevated ANA and may actually be associated with lower ANA prevalence, though this should never be construed as a health benefit given smoking's overwhelming negative health impacts.